Viatris (VTRS) Stock Price & AI Analysis

$8.79
$0.37
(4.39%)
Pharmaceuticals

NASDAQ USA

May 16, 4:58 PM EDT
  • Market Cap.
    10.32B
  • Volume
    15.91M
  • Avg. Volume
    15.63M
  • Target Price
    $11.20
  • 52W Range
    6.85 - 13.55
  • RSI (14)
    55.41
  • Beta
    0.87
  • PEG Ratio
  • SMA 20
    5.01%
  • SMA 50
    3.16%
  • SMA 200
    -19.74%
  • Insider Owner
    2.54%
  • Insider Trans
    0.2%
  • Institution Owner
    82.95%
  • Institution Trans
    -1.28%
  • Short Interest
    48.71%
  • EPS next Y
    9.73

Viatris Company Profile

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women’s healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women’s healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Viatris | Latest news

VTRS CLASS ACTION: A Securities Fraud Lawsuit was filed on behalf of Viatris...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company’s senior executives for potential ...

Morningstar - 1 day ago

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the...

StockStory - 3 days ago

Shareholders that lost money on Viatris Inc.(VTRS) should contact Levi &...

NEW YORK, May 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover

Morningstar - 3 days ago

...INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in...

Foti, Jr., remind investors that they have until June 3, 2025 to file lead plaintiff applications in...

CBS 47 Fresno - 7 days ago

The Attractiveness of Investing In Viatris Inc

Barclays also remained covering VTRS and has decreased its forecast on June 23, 2023 with a “an Underweight” recommendation from previously “an Equal weight” rating. Barclays revised its rating ...

Knox Daily - 5 days ago

VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Viatris Inc. (NASDAQ: VTRS)?Did you purchase your shares between August 8, 2024 and February 26, 2025, inclusive?Did you lose money in your

Cordele Dispatch - 5 days ago

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the ...

Morningstar - 4 days ago

Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities...

The Law Offices of Frank R. Cruz announces that investors with losses related to Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) have opportunity to lead the securities fraud class ...

Morningstar - 4 days ago

DEADLINE ALERT for SOUN, ECG, VTRS: Law Offices of Howard G. Smith Reminds...

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines ...

The Shelby County Reporter - 14 hours ago

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors...

NEW YORK, May 11, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris Inc. (“Viatris” or the “Company”) ( ...

The Andalusia Star-News - 5 days ago